<?xml version="1.0" encoding="UTF-8"?><html>
   <div tagx="ui">s13063-014-0530-z</div>
   <div tagx="ji">1745-6215</div>
   <head>
      <div tagx="dochead">Study protocol</div>
      <div tagx="bibl">
         <div tagx="title">
            <p>Effects of adaptive servo-ventilation therapy on cardiac function and remodeling in
               patients with chronic heart failure (SAVIOR-C): study protocol for a randomized controlled
               trial
            </p>
         </div>
         <ul tagx="aug">
            <li tagx="au">
               <span tagx="snm">Seino</span>
               <span tagx="fnm">Yoshihiko</span>
               <span tagx="insr"></span>
               <a href="y-seino@nms.ac.jp">y-seino@nms.ac.jp</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Momomura</span>
               <span tagx="fnm">Shin-ichi</span>
               <span tagx="insr"></span>
               <a href="momochan-tky@umin.net">momochan-tky@umin.net</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Kihara</span>
               <span tagx="fnm">Yasuki</span>
               <span tagx="insr"></span>
               <a href="ykihara@hiroshima-u.ac.jp">ykihara@hiroshima-u.ac.jp</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Adachi</span>
               <span tagx="fnm">Hitoshi</span>
               <span tagx="insr"></span>
               <a href="h-adachi@ops.dti.ne.jp">h-adachi@ops.dti.ne.jp</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Yasumura</span>
               <span tagx="fnm">Yoshio</span>
               <span tagx="insr"></span>
               <a href="yasumura@onh.go.jp">yasumura@onh.go.jp</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Yokoyama</span>
               <span tagx="fnm">Hiroyuki</span>
               <span tagx="insr"></span>
               <a href="hiyokoya@hctv.ne.jp">hiyokoya@hctv.ne.jp</a>
            </li>
            <li tagx="au">
               <div tagx="cnm">for the SAVIOR-C investigators</div>
            </li>
         </ul>
         <ul tagx="insg">
            <li tagx="ins">
               <p>Department of Cardiology, Cardiovascular Center, Nippon Medical School Chiba Hokusoh
                  Hospital, 1715 Kamagari, Inzai 270-1694, Chiba, Japan
               </p>
            </li>
            <li tagx="ins">
               <p>Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University,
                  1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, Saitama, Japan
               </p>
            </li>
            <li tagx="ins">
               <p>Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical
                  &amp; Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Hiroshima, Japan
               </p>
            </li>
            <li tagx="ins">
               <p>Division of Cardiology, Gunma Prefectural Cardiovascular Center, 3-12 Kamiizumi-machi,
                  Maebashi 371-0004, Gunma, Japan
               </p>
            </li>
            <li tagx="ins">
               <p>Cardiovascular Division, Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku 540-0006,
                  Osaka, Japan
               </p>
            </li>
            <li tagx="ins">
               <p>Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center,
                  5-7-1 Fujishirodai, Suita 565-8565, Osaka, Japan
               </p>
            </li>
         </ul>
         <span tagx="source">Trials</span>
         <span tagx="issn">1745-6215</span>
         <span tagx="pubdate">2015</span>
         <span tagx="volume">16</span>
         <span tagx="issue">1</span>
         <span tagx="fpage">14</span>
         <a href="http://www.trialsjournal.com/content/16/1/14">http://www.trialsjournal.com/content/16/1/14</a>
         <div tagx="xrefbib">
            <div tagx="pubidlist">
               <span tagx="pubid">10.1186/s13063-014-0530-z</span>
            </div>
         </div>
      </div>
      <div tagx="history">
         <span tagx="rec">
            <div tagx="date">
               <span tagx="day">10</span>
               <span tagx="month">9</span>
               <span tagx="year">2014</span>
            </div>
         </span>
         <span tagx="acc">
            <div tagx="date">
               <span tagx="day">19</span>
               <span tagx="month">12</span>
               <span tagx="year">2014</span>
            </div>
         </span>
         <span tagx="pub">
            <div tagx="date">
               <span tagx="day">16</span>
               <span tagx="month">1</span>
               <span tagx="year">2015</span>
            </div>
         </span>
      </div>
      <div tagx="cpyrt">
         <span tagx="year">2015</span>
         <div tagx="collab">Seino et al.; licensee BioMed Central.</div>
         <div tagx="note">This is an Open Access article distributed under the terms of the Creative Commons
            Attribution License (
            <a href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided
            the original work is properly credited. The Creative Commons Public Domain Dedication
            waiver (
            <a href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated.
         </div>
      </div>
      <ul tagx="kwdg">
         <li tagx="kwd">Adaptive servo-ventilation</li>
         <li tagx="kwd">Chronic heart failure</li>
         <li tagx="kwd">Noninvasive positive pressure ventilation</li>
         <li tagx="kwd">Left ventricular remodeling</li>
         <li tagx="kwd">Left ventricular ejection fraction</li>
         <li tagx="kwd">Cardiac function</li>
         <li tagx="kwd">Prognosis</li>
         <li tagx="kwd">Quality of life</li>
         <li tagx="kwd">Nonpharmacotherapy</li>
         <li tagx="kwd">Sleep-disordered breathing</li>
      </ul>
      <div id="abstract" tag="abstract">
         <div id="">
            <div tagx="st">
               <h2>Abstract</h2>
            </div>
            <div id="">
               <div tagx="st">
                  <h3>Background</h3>
               </div>
               <p>Adaptive servo-ventilation (ASV) therapy, which is a form of noninvasive positive
                  pressure ventilation therapy and uses an innovative ventilator that has simple operability
                  and provides good patient adherence, potentially has therapeutic benefits—suppression
                  of the deterioration and progression of chronic heart failure (CHF) and a reduction
                  in the number of repeated hospitalizations. Therefore, ASV therapy draws attention
                  as a novel, noninvasive nonpharmacotherapy for patients with CHF owing to its hemodynamics-improving
                  effect, and it is currently being accepted in real-world clinical settings in Japan.
                  However, clinical evidence sufficient for treatment recommendation is lacking because
                  a multicenter, randomized, controlled study of ASV therapy has never been conducted.
               </p>
            </div>
            <div id="">
               <div tagx="st">
                  <h3>Methods/Design</h3>
               </div>
               <p>The present study is a confirmatory, prospective, multicenter, collaborative, open-label,
                  blinded-endpoint, parallel-group, randomized, controlled study. At 40 medical institutions
                  in Japan, 200 Japanese outpatients with mild to severe CHF (age: ≥ 20 years; New York
                  Heart Association classification: greater than or equal to class II) will be randomly
                  assigned to either of the following two study groups: the ASV group, in which 100
                  outpatients undergo guideline-directed medical therapy and ASV therapy for 24 weeks;
                  and the control group, in which 100 outpatients undergo only guideline-directed medical
                  therapy for 24 weeks. The objective of the present study is to confirm whether the
                  ASV group is superior to the control group concerning the improvement of left ventricular
                  contractility and remodeling, both assessed by two-dimensional echocardiography. Furthermore,
                  the present study will also secondarily examine the effects of ASV therapy on the
                  prognosis and quality of life of patients with CHF.
               </p>
            </div>
            <div id="">
               <div tagx="st">
                  <h3>Discussion</h3>
               </div>
               <p>ASV therapy using the device has the potential to provide therapeutic benefits based
                  on its simple operability and good patient adherence and possesses the potential to
                  improve left ventricular contractility and remodeling. Therefore, the present study
                  is expected to afford more solid scientific evidence regarding ASV therapy as a novel,
                  noninvasive, nonpharmacological, in-home, long-term ventilation therapy for patients
                  with mild to severe CHF.
               </p>
            </div>
            <div id="">
               <div tagx="st">
                  <h3>Trial registration</h3>
               </div>
               <p>UMIN identifier: 
                  <a href="UMIN000006549">UMIN000006549</a>, registered on 17 October, 2011.
               </p>
            </div>
         </div>
      </div>
   </head>
   <div id="">
      <div tagx="st">
         <h2>Background</h2>
      </div>
      <p>In recent years, pharmacotherapy for chronic heart failure (CHF) has made remarkable
         progress. Furthermore, nonpharmacotherapies (for example, cardiac resynchronization
         therapy using an implantable cardioverter-defibrillator and comprehensive cardiac
         rehabilitation) have shown a given level of efficacy. However, patients with severe
         CHF still have a poor life prognosis and are often and repeatedly admitted to the
         hospital in the chronic clinical course of the disease. In addition, there are many
         patients whose symptoms of pulmonary congestion (for example, dyspnea and orthopnea)
         as well as quality of life are not sufficiently improved by existing therapeutic modalities.
      </p>
      <p>Noninvasive positive pressure ventilation (NPPV) therapy has been reported to improve
         not only dyspnea and respiratory distress caused by cardiogenic pulmonary edema but
         also cardiovascular hemodynamics 
         <span tagx="abbrgrp">
            <span tagx="abbr">1</span>
         </span>. Namely, NPPV therapy is beneficial for both the respiratory and hemodynamic functions
         of patients with heart failure. In Japan, NPPV therapy is recommended for patients
         with acute heart failure who do not respond to oxygen therapy as a therapy categorized
         to class I in treatment recommendation and to A in evidence level 
         <span tagx="abbrgrp">
            <span tagx="abbr">2</span>
         </span>. These facts lead us to conjecture that NPPV therapy is potentially effective for
         patients presenting with symptoms that are attributable to the insufficient long-term
         management of pulmonary congestion/edema (for example, dyspnea at rest, intense fatigability,
         orthopnea, and paroxysmal nocturnal dyspnea). Nevertheless, NPPV therapy has not become
         established as a therapeutic modality for CHF because conventional medical devices
         for NPPV therapy are difficult to use for a long period due to their problems (for
         example, cumbersome operability of the devices and poor patient adherence).
      </p>
      <p>Adaptive servo-ventilation (ASV) therapy, which is a form of NPPV therapy and uses
         an innovative ventilator AutoSet CS™ (Teijin Pharma Limited, Tokyo, Japan), potentially
         has the following mechanistic features that differ from conventional NPPV therapy
         including continuous positive airway pressure and bi-level positive airway pressure:
         1) ASV therapy appropriately sustains ventilation by instantaneously detecting a decay
         in spontaneous ventilation of the patient and by providing support pressure in concert
         with his/her respiratory flow patterns; and 2) ASV therapy presents more physiological
         synchronization with the respiratory patterns 
         <span tagx="abbrgrp">
            <span tagx="abbr">3</span>
         </span>. ASV therapy potentially has therapeutic benefits—suppression of the deterioration
         and progression of CHF and a reduction in the number of repeated hospitalizations—based
         on the simple operability of the device and good patient adherence as compared with
         conventional NPPV therapy. Thus, it draws attention as a novel, noninvasive nonpharmacotherapy
         for patients with CHF owing to its hemodynamics-improving effect. Prior to the present
         study, we conducted a multicenter, retrospective, observational study [
         <i>S</i>tudy on the effects of 
         <i>A</i>daptive servo-
         <i>V</i>entilation 
         <i>I</i>n patients with chr
         <i>O</i>nic heart failu
         <i>R</i>e: 
         <i>R</i>eal-world, multicenter, retrospective, observational study (SAVIOR-R)] for the objective
         of examining the real-world practical efficacy and limitations of ASV therapy for
         patients with CHF in Japan 
         <span tagx="abbrgrp">
            <span tagx="abbr">4</span>
         </span>. SAVIOR-R suggested that ASV therapy possibly improves the cardiac function and symptoms
         of patients with CHF, regardless of the severity of sleep-disordered breathing. Furthermore,
         prior single-center clinical studies indicated that ASV therapy improves left ventricular
         contractility and induces cardiac reverse remodeling 
         <span tagx="abbrgrp">
            <span tagx="abbr">5</span>
         </span>, that pulmonary congestion improved by positive end-expiratory pressure suppresses
         sympathetic nerve activity 
         <span tagx="abbrgrp">
            <span tagx="abbr">6</span>
         </span>-
         <span tagx="abbrgrp">
            <span tagx="abbr">8</span>
         </span>, and that ASV therapy improves left ventricular ejection fraction (LVEF) and reduces
         brain natriuretic peptide levels 
         <span tagx="abbrgrp">
            <span tagx="abbr">9</span>
         </span> and further cardiac events (death and hospitalization) 
         <span tagx="abbrgrp">
            <span tagx="abbr">10</span>
         </span>.
      </p>
      <p>The present study is a confirmatory study of SAVIOR-R and aims to assess the effects
         of ASV therapy on left ventricular contractility and remodeling in patients with mild
         to severe CHF in a multicenter, randomized, controlled study. Left ventricular contractility
         and remodeling will be assessed by two-dimensional echocardiography.
      </p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Methods/Design</h2>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Study design and study organization</h3>
         </div>
         <p>The present study (SAVIOR-C) is a confirmatory, prospective, multicenter, collaborative,
            open-label, blinded-endpoint, parallel-group, randomized, controlled study. The target
            number of patients is 200, and the study groups consist of the ASV group and the control
            group. The present study will last for 24 weeks, and the primary and secondary endpoints
            will be assessed at baseline (8 weeks prior to treatment onset through treatment onset),
            at week 12 of study (±4 weeks), on the day of study discontinuation, or on the day
            of study completion at week 24 (±4 weeks).
         </p>
         <p>The Steering Committee will perform activities (for example, selection of study sites,
            investigators, and others, preparation and revision of the protocol and other documents,
            interpretation of questions about the study plan, coordination with investigators,
            establishment of the handling criteria for patients and data, determination of the
            acceptance of patients and data, interpretation of the study results, and preparation
            of study conclusions; Additional file 
            <div tagx="supplr">1</div>). The Central Adjudication Committee will confirm in a blind manner the absence of
            any problems in measurement conditions and results of two-dimensional echocardiographic
            parameters, including LVEF—the primary endpoint—and in the subinvestigator’s assessment
            on CHF deterioration—the secondary endpoint, and will check whether adverse events
            and ventilator failure have developed in a biased fashion to a given group. The Study
            Promotion Committee will afford study support to study sites. The present study has
            been approved by the Ethical Review Board at each participating medical institution
            (Additional file 
            <div tagx="supplr">2</div>) before its conduct in accordance with the Declaration of Helsinki. Prior to enrollment,
            all patients will provide written informed consent to be involved in the present study.
            The present trial is registered (UMIN identifier: UMIN000006549, registered on 17
            October, 2011).
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Patients</h3>
         </div>
         <p>SAVIOR-C will assign 200 Japanese outpatients with CHF, who meet all of the inclusion
            criteria and do not fall under any of the exclusion criteria (Table 
            <span tagx="tblr">1</span>), to either of the following two study groups at 40 medical institutions in Japan
            based on assignment adjustment factors [age: &lt; 65 years/≥ 65 years: gender: male/female:,
            and New York Heart Association (NYHA) classification: class II/III]: the ASV group
            and the control group (Figure 
            <div tagx="figr">1</div>).
            
            
         </p>
         <table>
            <div tagx="title">
               <p>Table 1</p>
            </div>
            <caption>
               <p>
                  <b>Inclusion and exclusion criteria</b>
               </p>
            </caption>
            <tgroup>
               <colspec></colspec>
               <colspec></colspec>
               <thead>
                  <tr>
                     <td>
                        <p>
                           <b>Inclusion criteria</b>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>Exclusion criteria</b>
                        </p>
                     </td>
                  </tr>
               </thead>
               <div tagx="tfoot">
                  <p>*Week 8 before enrollment through day of enrollment. ASV, adaptive servo-ventilation;
                     CHF, chronic heart failure; LVEF, left ventricular ejection fraction; NYHA, New York
                     Heart Association.
                  </p>
               </div>
               <tbody>
                  <tr>
                     <td>
                        <p>1. Men and women</p>
                     </td>
                     <td>
                        <p>1. Patients with any of the following symptoms:</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>2. Age ≥20 years at informed consent acquisition</p>
                     </td>
                     <td>
                        <p>- Acute sinusitis or otitis media</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>3. Patients with CHF who are undergoing guideline-directed medical therapy</p>
                     </td>
                     <td>
                        <p>- Symptoms predisposing vomiting in the mask</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>4. Patients with CHF capable of using the ASV device at home as outpatients after
                           enrollment
                        </p>
                     </td>
                     <td>
                        <p>- Incapable of swallowing airway secretions</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>- Pneumothorax or mediastinal emphysema</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>5. Patients whose NYHA class at baseline* is greater than or equal to II</p>
                     </td>
                     <td>
                        <p>- Recent cranial injury or surgery</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>6. Patients whose LVEF at baseline* is &lt;40%</p>
                     </td>
                     <td>
                        <p>- Chronic hypoventilation</p>
                     </td>
                  </tr>
                  <tr>
                     <td></td>
                     <td>
                        <p>2. Patients at risk of developing any of the following symptoms due to the use of
                           the ASV device
                        </p>
                     </td>
                  </tr>
                  <tr>
                     <td></td>
                     <td>
                        <p>- Hypotension or a significant reduction in intravascular volume</p>
                     </td>
                  </tr>
                  <tr>
                     <td></td>
                     <td>
                        <p>- Intense nasal bleeding leading to the risk of pulmonary aspiration</p>
                     </td>
                  </tr>
                  <tr>
                     <td></td>
                     <td>
                        <p>3. Patients incapable of giving voluntary consent</p>
                     </td>
                  </tr>
                  <tr>
                     <td></td>
                     <td>
                        <p>4. Patients with a history of undergoing the treatment of CHF by ASV at home</p>
                     </td>
                  </tr>
                  <tr>
                     <td></td>
                     <td>
                        <p>5. Patients who are enrolled in another clinical study or trial</p>
                     </td>
                  </tr>
                  <tr>
                     <td></td>
                     <td>
                        <p>6. Patients diagnosed with or suspected of dementia</p>
                     </td>
                  </tr>
                  <tr>
                     <td></td>
                     <td>
                        <p>7. Patients whom the attending physician has considered ineligible for this study</p>
                     </td>
                  </tr>
               </tbody>
            </tgroup>
         </table>
         <div tagx="fig">
            <div tagx="title">
               <p>Figure 1</p>
            </div>
            <caption>
               <p>Flow diagram of SAVIOR-C. </p>
            </caption>
            <div tagx="text">
               <p>
                  <b>Flow diagram of SAVIOR-C.</b> AHI, apnea-hypopnea index; ASV, adaptive servo-ventilation; GDMT, guideline-directed
                  medical therapy; NYHA, New York Heart Association.
               </p>
            </div>
            <div tagx="graphic"></div>
         </div>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Study treatment</h3>
         </div>
         <p>Study treatment initiates within 8 weeks after provision of the verbal and written
            explanations by the investigator to each patient. Eligibility check, enrollment, and
            randomization of each patient are performed between the provision and the study onset.
            Patients in the ASV group undergo ASV therapy in addition to guideline-directed medical
            therapy 
            <span tagx="abbrgrp">
               <span tagx="abbr">11</span>
            </span> for the study period (study onset through week 24 of study), while patients in the
            control group undergo only guideline-directed medical therapy for the study period.
            Patients in the ASV therapy group, who are in bed, undergo the ASV therapy each night
            during the study period.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Endpoints</h3>
         </div>
         <p>Efficacy, safety, and other aspects of ASV therapy will be assessed. The primary endpoint
            for efficacy is LVEF, a variable for the evaluation of heart failure that is applicable
            to a randomized controlled study of prospective, open-label, blinded-endpoint design.
            Two-dimensional echocardiography will be conducted at each institution in accordance
            with the procedures specified for SAVIOR-C. LVEF, left ventricular end-systolic volume,
            and left ventricular end-diastolic volume will be calculated according to the biplane
            Simpson’s method 
            <span tagx="abbrgrp">
               <span tagx="abbr">12</span>
            </span>. Furthermore, the Central Adjudication Committee will determine in a blinded fashion
            the acceptability of the echocardiograms to be submitted by the investigators.
         </p>
         <p>The secondary endpoints for efficacy are 1) clinical events (death, hospitalization,
            treatment changes, and long-lasting (≥12 weeks) deterioration of symptoms) 
            <span tagx="abbrgrp">
               <span tagx="abbr">13</span>
            </span> to be finally adjudicated by the Central Adjudication Committee in a blind fashion,
            2) brain natriuretic peptide to be measured at each participating medical institution,
            and 3) clinical composite response to be categorized (worsened, unchanged, and improved)
            based on NYHA classification and clinical events.
         </p>
         <p>The endpoints for safety are adverse events and ventilator failure. The endpoints
            for other aspects of ASV therapy are as follows: 1) those to be collected via the
            case report form - patient background, quality of life, activities of daily living,
            vital signs, physical findings, echocardiograms, chest radiographs, hematology results,
            sleep study results (for example, apnea-hypopnea index), and usage of the ventilator,
            all from the ASV and control groups; and 2) those to be collected via electronic means—echocardiograms
            and air flow in the sleep study from the ASV and control groups, and usage of the
            ventilator from the ASV group. The schedule of observations, examinations, and assessments
            is shown in Table 
            <span tagx="tblr">2</span>.
            
         </p>
         <table>
            <div tagx="title">
               <p>Table 2</p>
            </div>
            <caption>
               <p>
                  <b>Schedule for observation, testing, and assessment</b>
               </p>
            </caption>
            <tgroup>
               <colspec></colspec>
               <colspec></colspec>
               <colspec></colspec>
               <colspec></colspec>
               <colspec></colspec>
               <thead>
                  <tr>
                     <td>
                        <p>
                           <b>Acquisition means</b>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>Examination items</b>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>Timing (allowable range)</b>
                        </p>
                     </td>
                  </tr>
               </thead>
               <div tagx="tfoot">
                  <p>
                     <sup>1</sup>Without the ASV device, a device for sleep study (type 1, 2, or 3) is used. 
                     <sup>2</sup>Without the ASV device, a device for sleep study (types 1, 2, 3, or 4) is used. ASV,
                     adaptive servo-ventilation; NYHA, New York Heart Association.
                  </p>
               </div>
               <tbody>
                  <tr>
                     <td></td>
                     <td></td>
                     <td>
                        <p>Baseline: week 8 before enrollment through day of enrollment</p>
                     </td>
                     <td>
                        <p>Week 12 (±4 weeks)</p>
                     </td>
                     <td>
                        <p>Day of study discontinuation or day of study completion at week 24 (±4 weeks)</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Case report form</p>
                     </td>
                     <td>
                        <p>Patient background</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>Combined therapy</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Symptoms (NYHA class and self-assessment of daytime sleepiness)</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Quality of life and activities of daily living</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Vital signs</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Physical examination</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Echocardiography</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Chest X-ray</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Brain natriuretic peptide</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Hematology</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Sleep study</p>
                     </td>
                     <td>
                        <p>×
                           <sup>1</sup>
                        </p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>Wherever possible
                           <sup>2</sup>
                        </p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Cardiac event</p>
                     </td>
                     <td></td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Usage of the ventilator in the ASV group</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Adverse events</p>
                     </td>
                     <td></td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Electronic means</p>
                     </td>
                     <td>
                        <p>Echocardiogram</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Air flow in the sleep study</p>
                     </td>
                     <td>
                        <p>×
                           <sup>1</sup>
                        </p>
                     </td>
                     <td></td>
                     <td>
                        <p>Wherever possible
                           <sup>2</sup>
                        </p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Usage of the ventilator in the ASV group</p>
                     </td>
                     <td></td>
                     <td>
                        <p>×</p>
                     </td>
                     <td>
                        <p>×</p>
                     </td>
                  </tr>
               </tbody>
            </tgroup>
         </table>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Statistical methods and sample size</h3>
         </div>
         <p>The subgroup analysis of patients with reduced LVEF (&lt;40%) in SAVIOR-R revealed a
            6.9% improvement (before ASV therapy: 26.5 ± 7.4%; after ASV therapy: 33.4 ± 13.0%).
            In SAVIOR-R, furthermore, a statistical analysis considering time-course changes in
            LVEF indicated that the LVEF-improving effect of ASV therapy tended to appear at week
            12 of the study or later. LVEF remained unchanged when ASV therapy was not conducted
            and improved by 5% when ASV therapy was conducted for 24 weeks. The target number
            of patients in SAVIOR-C was calculated based on an assumed standard deviation of 7.4
            in reference to the pre-ASV therapy value. Consequently, power exceeds 80% when a
            group includes not less than 90 patients. Since sufficient power is obtained when
            a group includes 100 patients in consideration of a presumed withdrawal rate of 10%,
            a total of 200 patients—100 patients per study group—were established.
         </p>
         <p>The efficacy analysis set consists of the full analysis set and the per-protocol set
            to be defined below. The full analysis set consists of patients who initiated ASV
            therapy, from whom the following patients are excluded: 1) patients in the ASV group
            who never used the ventilator during the study period; and 2) patients from whom the
            efficacy data after study onset were not obtained at all during the study period.
            The per-protocol set consists of patients in the full analysis set, from whom the
            following patients are excluded: 1) patients who deviated from the inclusion criteria
            or fell under any of the exclusion criteria; 2) patients who fell under any of prohibited
            combination therapies; and 3) patients with poor compliance in ventilator use. Poor
            compliance is defined as an ASV therapy practice rate of &lt; 80% (number of days from
            day of treatment onset through day of treatment discontinuation or day of study completion).
            The safety of the study groups will be analyzed statistically on an intention-to-treat
            basis.
         </p>
         <p>The aim of the statistical analyses is to examine the efficacy and safety of ASV therapy
            for the target number of 200 patients by comparing the ASV group with the control
            group with respect to the primary endpoint for efficacy—LVEF—and to the measured values
            of respective secondary endpoints. The detailed procedures for randomized assignment
            will be determined but will not be informed to the subinvestigators at each participating
            medical institution. The details and technical methods of the statistical analyses
            will be described in the statistical analysis plan to be prepared prior to database
            lock. Statistical tests (for example, chi-square test using the contingency table,
            Fisher’s exact probability test, Kruskal-Wallis test, and analysis of variance) will
            be used in accordance with the scale of demographic data. Furthermore, a two-tailed
            probability of 15% will be established as an index of intergroup homogeneity. The
            data to be collected in the present study will be analyzed by the Japan-Clinical Research
            Support Unit that is completely independent from study organizations.
         </p>
      </div>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Discussion</h2>
      </div>
      <p>The 5-year survival rates of patients with CHF in the 1990s were as low as 25% and
         38% for males and females, respectively 
         <span tagx="abbrgrp">
            <span tagx="abbr">14</span>
         </span>. The 5-year survival rate of patients with CHF who had left ventricular systolic
         dysfunction improved to 52% 
         <span tagx="abbrgrp">
            <span tagx="abbr">15</span>
         </span>. However, in both males and females, CHF requiring hospitalization was more “malignant”
         than many of the common types of cancer 
         <span tagx="abbrgrp">
            <span tagx="abbr">16</span>
         </span>. The 5-year survival rates of patients with CHF aged 65 to 74 years were 54% and
         40% for males and females, respectively 
         <span tagx="abbrgrp">
            <span tagx="abbr">17</span>
         </span>. Furthermore, the 5-year survival rates of patients with CHF categorized to stages
         A, B, C, and D were 97%, 96%, 75%, and 20%, respectively 
         <span tagx="abbrgrp">
            <span tagx="abbr">18</span>
         </span>. These epidemiologic data clearly indicate that CHF, once progressed, still exhibits
         a poor life prognosis despite recent progress in therapeutic modalities and that preventing
         the deterioration and progression of CHF severe enough to require hospitalization
         is critically important for the further betterment of the survival rate of patients
         with CHF, and also indicates the need to develop a novel therapeutic modality which
         is useful for the prevention and progression of CHF, apart from pharmacotherapies
         and nonpharmacoptherapies that are recommended by guidelines 
         <span tagx="abbrgrp">
            <span tagx="abbr">11</span>
         </span>,
         <span tagx="abbrgrp">
            <span tagx="abbr">19</span>
         </span>,
         <span tagx="abbrgrp">
            <span tagx="abbr">20</span>
         </span>.
      </p>
      <p>Nonpharmacotherapies that are currently applied to the treatment of CHF include 1)
         cardiac resynchronization therapy using an implantable cardioverter-defibrillator
         to treat heart failure involving dyssynchrony of left ventricular contraction 
         <span tagx="abbrgrp">
            <span tagx="abbr">21</span>
         </span>-
         <span tagx="abbrgrp">
            <span tagx="abbr">23</span>
         </span>, 2) comprehensive cardiac rehabilitation including exercise therapy 
         <span tagx="abbrgrp">
            <span tagx="abbr">24</span>
         </span>-
         <span tagx="abbrgrp">
            <span tagx="abbr">26</span>
         </span>, 3) Waon therapy—soothing warmth therapy, a novel systemic treatment for heart failure
         by means of dry far-infrared radiation sauna equipment 
         <span tagx="abbrgrp">
            <span tagx="abbr">27</span>
         </span>,
         <span tagx="abbrgrp">
            <span tagx="abbr">28</span>
         </span>, 4) surgical approaches including coronary revascularization 
         <span tagx="abbrgrp">
            <span tagx="abbr">29</span>
         </span>, on- or off-pump coronary artery bypass grafting 
         <span tagx="abbrgrp">
            <span tagx="abbr">30</span>
         </span>, mitral annuloplasty 
         <span tagx="abbrgrp">
            <span tagx="abbr">31</span>
         </span>, and mitral valve replacement 
         <span tagx="abbrgrp">
            <span tagx="abbr">32</span>
         </span> to treat functional mitral regurgitation caused by left ventricular volume expansion
         due to left ventricular remodeling, 5) auxiliary circulation including intraaortic
         balloon pumping 
         <span tagx="abbrgrp">
            <span tagx="abbr">33</span>
         </span> and extracorporeal auxiliary artificial heart 
         <span tagx="abbrgrp">
            <span tagx="abbr">34</span>
         </span>, and 6) heart transplantation 
         <span tagx="abbrgrp">
            <span tagx="abbr">35</span>
         </span>. Nevertheless, none of these therapeutic modalities are practicable at home, and
         all of them cause great physical, mental, and economic burdens to the patient. The
         estimated medical cost of pharmacotherapy for the treatment of heart failure in the
         United States is $3.2 billion annually, and about three-quarters of the total treatment
         costs for heart failure are related with admissions to the hospital, in-hospital treatment,
         and nursing care in nursing homes 
         <span tagx="abbrgrp">
            <span tagx="abbr">36</span>
         </span>. Heart failure accounts for 56% of causes of death for patients with NYHA class IV,
         while sudden death (for example, fatal ventricular arrhythmias) accounts for 64% and
         59% of causes of death for patients with NYHA classes II and III, respectively 
         <span tagx="abbrgrp">
            <span tagx="abbr">37</span>
         </span>. In Japan, furthermore, the percentages of patients categorized to NYHA classes I
         to IV at admission were 1.2%, 11.4%, 44.6%, and 42.9%, respectively 
         <span tagx="abbrgrp">
            <span tagx="abbr">2</span>
         </span>. Therefore, it is vitally important in the therapeutic strategy and medical economics
         of CHF to reasonably reduce the percentages of NYHA class III and IV patients, as
         well as the number of repeated admissions to hospital.
      </p>
      <p>Positive end-expiratory pressure generated by NPPV therapy has the following physiologic
         mechanisms: alleviation of preload via a decrease in venous return 
         <span tagx="abbrgrp">
            <span tagx="abbr">38</span>
         </span>, suppression of sympathetic overactivity 
         <span tagx="abbrgrp">
            <span tagx="abbr">6</span>
         </span>,
         <span tagx="abbrgrp">
            <span tagx="abbr">7</span>
         </span>, and relief of afterload via a reduction in transmural pressure 
         <span tagx="abbrgrp">
            <span tagx="abbr">39</span>
         </span>,
         <span tagx="abbrgrp">
            <span tagx="abbr">40</span>
         </span>. The activation of these mechanisms is also expected during in-home therapy for the
         treatment of CHF. Nevertheless, conventional NPPV therapy has the limitations of cumbersome
         operability of the ventilator and poor patient adherence, and has not sufficiently
         diffused as a therapeutic modality for CHF that brings therapeutic benefits. AutoSet
         CS™, originally developed for the treatment of sleep-disordered breathing, demonstrates
         extensive improvements in the abovementioned drawbacks of the conventional medical
         devices for NPPV therapy. ASV therapy is being accepted rapidly among Japanese cardiologists
         who expect the circulatory and respiratory function-improving effects of the device.
         SAVIOR-R, which investigated the practice efficacy and limitations of ASV therapy
         for real-world patients with CHF in Japan, clearly revealed these facts and also suggested,
         as with other prior studies 
         <span tagx="abbrgrp">
            <span tagx="abbr">9</span>
         </span>,
         <span tagx="abbrgrp">
            <span tagx="abbr">10</span>
         </span>, that ASV therapy improves the cardiac function of patients with CHF, regardless
         of the severity of sleep-disordered breathing. The present study plans to investigate
         these expectations in terms of the multicenter, randomized, controlled study because
         of its confirmatory nature of SAVIOR-R.
      </p>
      <p>ASV therapy has the potential to improve left ventricular contractility via reverse
         remodeling, exerting therapeutic benefits based on the simple operability of the device
         and good patient adherence as compared with conventional NPPV therapy, and improving
         the prognosis and quality of life of patients with CHF. Therefore, the present study
         is expected to afford more solid scientific evidence about ASV therapy as a novel,
         noninvasive, nonpharmacological, in-home, long-term ventilation therapy for patients
         with CHF.
      </p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Trial status</h2>
      </div>
      <p>The trial is ongoing.</p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Abbreviations</h2>
      </div>
      <p>ASV: adaptive servo-ventilation</p>
      <p>CHF: chronic heart failure</p>
      <p>LVEF: left ventricular ejection fraction</p>
      <p>NPPV: noninvasive positive pressure ventilation</p>
      <p>NYHA: New York Heart Association</p>
      <p>SAVIOR-C: a 
         <i>C</i>onfirmatory, multicenter, randomized, controlled 
         <i>S</i>tudy of 
         <i>A</i>daptive servo-
         <i>V</i>entIlation 
         <i>I</i>n patients with chr
         <i>O</i>nic hea
         <i>R</i>t failure
      </p>
      <p>SAVIOR-R: 
         
         <i>S</i>tudy on the effects of 
         <i>A</i>daptive servo-
         <i>V</i>entilation 
         <i>I</i>n patients with chr
         <i>O</i>nic heart failu
         <i>R</i>e: 
         <i>R</i>eal-world, multicenter, retrospective, observational study
      </p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Competing interests</h2>
      </div>
      <p>The authors declare that they have no competing interests relevant to the manuscript.
         This study (SAVIOR-C) will be supported by the Comprehensive Support Project for Clinical
         Research of Lifestyle-Related Disease of the Public Health Research Foundation. All
         decisions concerning the planning, implementation, and publication of this study will
         be made by the Steering Committee of this study.
      </p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Authors’ contributions</h2>
      </div>
      <p>YS and SM conceived the study design that was further developed and modified by YK,
         HA, YY, and HY. All authors read and approved the final version of the manuscript.
      </p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Authors’ information</h2>
      </div>
      <p>The investigators for SAVIOR-C are listed in Additional file 
         <div tagx="supplr">3</div>.
      </p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Additional files</h2>
      </div>
      <div tagx="suppl">
         <div tagx="title">
            <p>Additional file 1:</p>
         </div>
         <div tagx="text">
            <p>
               <b>Lists of the Steering Committee, Central Adjudication Committee, Study Promotion Committee,
                  and Advisors.
               </b>
            </p>
         </div>
         <div tagx="file">
            <p>Click here for file</p>
         </div>
      </div>
      <div tagx="suppl">
         <div tagx="title">
            <p>Additional file 2:</p>
         </div>
         <div tagx="text">
            <p>
               <b>A list of 41 Ethical Review Boards that approved SAVIOR-C.</b>
            </p>
         </div>
         <div tagx="file">
            <p>Click here for file</p>
         </div>
      </div>
      <div tagx="suppl">
         <div tagx="title">
            <p>Additional file 3:</p>
         </div>
         <div tagx="text">
            <p>
               <b>A list of investigators at the participating medical institutions of SAVIOR-C.</b>
            </p>
         </div>
         <div tagx="file">
            <p>Click here for file</p>
         </div>
      </div>
   </div>
   <div tagx="bm">
      <div tagx="ack">
         <div id="">
            <div tagx="st">
               <h2>Acknowledgments</h2>
            </div>
            <p>The research fund for SAVIOR-C was provided to the Comprehensive Support Project for
               Clinical Research of Lifestyle-Related Disease of the Public Health Research Foundation
               by Teijin Pharma Limited. The authors are grateful to Satoshi Sakima for his critical
               review of the manuscript.
            </p>
            <div id="">
               <div tagx="st">
                  <h3>Disclosures</h3>
               </div>
               <p>Any part or whole of the manuscript has never been published.</p>
            </div>
         </div>
      </div>
      <div tagx="refgrp">
         <div tagx="bibl">
            <div tagx="title">
               <p>Noninvasive ventilation in acute cardiogenic pulmonary edema</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Gray</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Goodacre</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Newby</span>
                  <span tagx="fnm">DE</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Masson</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Sampson</span>
                  <span tagx="fnm">F</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Nicholl</span>
                  <span tagx="fnm">J</span>
               </li>
            </ul>
            <ul tagx="insg">
               <li tagx="ins">
                  <p>3CPO Trialists</p>
               </li>
            </ul>
            <span tagx="source">N Engl J Med.</span>
            <span tagx="pubdate">2008</span>
            <span tagx="volume">359</span>
            <span tagx="fpage">142</span>
            <span tagx="lpage">151</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1056/NEJMoa0707992</span>
                  <span tagx="pubid">18614781</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Guidelines for treatment of acute heart failure (JCS 2011)</p>
            </div>
            <ul tagx="insg">
               <li tagx="ins">
                  <p>JCS Joint Working Group</p>
               </li>
            </ul>
            <span tagx="source">Circ J</span>
            <span tagx="pubdate">2013</span>
            <span tagx="volume">77</span>
            <span tagx="fpage">2157</span>
            <span tagx="lpage">2201</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1253/circj.CJ-66-0068</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration
                  in heart failure
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Teschler</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Döhring</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Wang</span>
                  <span tagx="fnm">YM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Berthon-Jones</span>
                  <span tagx="fnm">M</span>
               </li>
            </ul>
            <span tagx="source">Am J Respir Crit Care Med.</span>
            <span tagx="pubdate">2001</span>
            <span tagx="volume">164</span>
            <span tagx="fpage">614</span>
            <span tagx="lpage">619</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1164/ajrccm.164.4.9908114</span>
                  <span tagx="pubid">11520725</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="note">Momomura S, Seino Y, Kihara Y, Adachi H, Yasumura Y, Yokoyama H; the SAVIOR-R investigators.
               Adaptive servo-ventilation therapy using an innovative ventilator for patients with
               chronic heart failure: a real-world, multicenter, retrospective, observational study
               (SAVIOR-R). Heart Vessels. 2014. Epub ahead of print.
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Comparison of acute and chronic impact of adaptive servo-ventilation on left chamber
                  geometry and function in patients with chronic heart failure
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Haruki</span>
                  <span tagx="fnm">N</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Takeuchi</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kaku</span>
                  <span tagx="fnm">K</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Yoshitani</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kuwaki</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Tamura</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Abe</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Okazaki</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Tsutsumi</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Otsuji</span>
                  <span tagx="fnm">Y</span>
               </li>
            </ul>
            <span tagx="source">Eur J Heart Fail.</span>
            <span tagx="pubdate">2011</span>
            <span tagx="volume">13</span>
            <span tagx="fpage">1140</span>
            <span tagx="lpage">1146</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1093/eurjhf/hfr103</span>
                  <span tagx="pubid">21831914</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Short term effect of adaptive servo-ventilation on muscle sympathetic nerve activity
                  in patients with heart failure
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Harada</span>
                  <span tagx="fnm">D</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Joho</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Oda</span>
                  <span tagx="fnm">Y</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hirai</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Asanoi</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Inoue</span>
                  <span tagx="fnm">H</span>
               </li>
            </ul>
            <span tagx="source">Auton Neurosci.</span>
            <span tagx="pubdate">2011</span>
            <span tagx="volume">161</span>
            <span tagx="fpage">95</span>
            <span tagx="lpage">102</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.autneu.2010.12.001</span>
                  <span tagx="pubid">21195678</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Effect of adaptive servoventilation on muscle sympathetic nerve activity in patients
                  with chronic heart failure and central sleep apnea
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Joho</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Oda</span>
                  <span tagx="fnm">Y</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ushijima</span>
                  <span tagx="fnm">R</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hirai</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Inoue</span>
                  <span tagx="fnm">H</span>
               </li>
            </ul>
            <span tagx="source">J Card Fail.</span>
            <span tagx="pubdate">2012</span>
            <span tagx="volume">18</span>
            <span tagx="fpage">769</span>
            <span tagx="lpage">775</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.cardfail.2012.08.360</span>
                  <span tagx="pubid">23040112</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Differing effects of adaptive servoventilation and continuous positive airway pressure
                  on muscle sympathetic nerve activity in patients with heart failure
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Ushijima</span>
                  <span tagx="fnm">R</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Joho</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Akabane</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Oda</span>
                  <span tagx="fnm">Y</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Inoue</span>
                  <span tagx="fnm">H</span>
               </li>
            </ul>
            <span tagx="source">Circ J.</span>
            <span tagx="pubdate">2014</span>
            <span tagx="volume">78</span>
            <span tagx="fpage">1387</span>
            <span tagx="lpage">1395</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1253/circj.CJ-13-1468</span>
                  <span tagx="pubid">24705391</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Effectiveness of adaptive servo-ventilation for treating heart failure regardless
                  of the severity of sleep-disordered breathing
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Takama</span>
                  <span tagx="fnm">N</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kurabayashi</span>
                  <span tagx="fnm">M</span>
               </li>
            </ul>
            <span tagx="source">Circ J.</span>
            <span tagx="pubdate">2011</span>
            <span tagx="volume">75</span>
            <span tagx="fpage">1164</span>
            <span tagx="lpage">1169</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1253/circj.CJ-10-0831</span>
                  <span tagx="pubid">21378449</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Short-term prognosis of adaptive servo-ventilation therapy in patients with heart
                  failure
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Koyama</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Watanabe</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Igarashi</span>
                  <span tagx="fnm">G</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Terada</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Makabe</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ito</span>
                  <span tagx="fnm">H</span>
               </li>
            </ul>
            <span tagx="source">Circ J.</span>
            <span tagx="pubdate">2011</span>
            <span tagx="volume">75</span>
            <span tagx="fpage">710</span>
            <span tagx="lpage">712</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1253/circj.CJ-10-0956</span>
                  <span tagx="pubid">21266785</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>ACCF/AHA guideline for the management of heart failure: a report of the American College
                  of Cardiology Foundation/American Heart Association Task Force on practice guidelines
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Yancy</span>
                  <span tagx="fnm">CW</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Jessup</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bozkurt</span>
                  <span tagx="fnm">B</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Butler</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Casey</span>
                  <span tagx="fnm">DE</span>
                  <div tagx="suf">Jr</div>
               </li>
               <li tagx="au">
                  <span tagx="snm">Drazner</span>
                  <span tagx="fnm">MH</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Fonarow</span>
                  <span tagx="fnm">GC</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Geraci</span>
                  <span tagx="fnm">SA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Horwich</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Januzzi</span>
                  <span tagx="fnm">JL</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Johnson</span>
                  <span tagx="fnm">MR</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kasper</span>
                  <span tagx="fnm">EK</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Levy</span>
                  <span tagx="fnm">WC</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Masoudi</span>
                  <span tagx="fnm">FA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">McBride</span>
                  <span tagx="fnm">PE</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">McMurray</span>
                  <span tagx="fnm">JJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Mitchell</span>
                  <span tagx="fnm">JE</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Peterson</span>
                  <span tagx="fnm">PN</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Riegel</span>
                  <span tagx="fnm">B</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Sam</span>
                  <span tagx="fnm">F</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Stevenson</span>
                  <span tagx="fnm">LW</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Tang</span>
                  <span tagx="fnm">WH</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Tsai</span>
                  <span tagx="fnm">EJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Wilkoff</span>
                  <span tagx="fnm">BL</span>
               </li>
            </ul>
            <ul tagx="insg">
               <li tagx="ins">
                  <p>American College of Cardiology Foundation/American Heart Association Task Force on
                     Practice Guidelines
                  </p>
               </li>
            </ul>
            <span tagx="source">Circulation</span>
            <span tagx="pubdate">2013</span>
            <span tagx="volume">2013</span>
            <span tagx="issue">128</span>
            <span tagx="fpage">e240</span>
            <span tagx="lpage">e327</span>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Recommendations for chamber quantification: a report from the American Society of
                  Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification
                  Writing Group, developed in conjunction with the European Association of Echocardiography,
                  a branch of the European Society of Cardiology
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Lang</span>
                  <span tagx="fnm">RM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bierig</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Devereux</span>
                  <span tagx="fnm">RB</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Flachskampf</span>
                  <span tagx="fnm">FA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Foster</span>
                  <span tagx="fnm">E</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Pellikka</span>
                  <span tagx="fnm">PA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Picard</span>
                  <span tagx="fnm">MH</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Roman</span>
                  <span tagx="fnm">MJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Seward</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Shanewise</span>
                  <span tagx="fnm">JS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Solomon</span>
                  <span tagx="fnm">SD</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Spencer</span>
                  <span tagx="fnm">KT</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Sutton</span>
                  <span tagx="fnm">MS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Stewart</span>
                  <span tagx="fnm">WJ</span>
               </li>
            </ul>
            <ul tagx="insg">
               <li tagx="ins">
                  <p>Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines
                     and Standards Committee; European Association of Echocardiography
                  </p>
               </li>
            </ul>
            <span tagx="source">J Am Soc Echocardiogr</span>
            <span tagx="pubdate">2005</span>
            <span tagx="volume">18</span>
            <span tagx="fpage">1440</span>
            <span tagx="lpage">1463</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.echo.2005.10.005</span>
                  <span tagx="pubid">16376782</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Proposal for a new clinical end point to evaluate the efficacy of drugs and devices
                  in the treatment of chronic heart failure
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Packer</span>
                  <span tagx="fnm">M</span>
               </li>
            </ul>
            <span tagx="source">J Card Fail.</span>
            <span tagx="pubdate">2001</span>
            <span tagx="volume">7</span>
            <span tagx="fpage">176</span>
            <span tagx="lpage">182</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1054/jcaf.2001.25652</span>
                  <span tagx="pubid">11420770</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Survival after the onset of congestive heart failure in Framingham Heart Study subjects</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Ho</span>
                  <span tagx="fnm">KK</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Anderson</span>
                  <span tagx="fnm">KM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kannel</span>
                  <span tagx="fnm">WB</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Grossman</span>
                  <span tagx="fnm">W</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Levy</span>
                  <span tagx="fnm">D</span>
               </li>
            </ul>
            <span tagx="source">Circulation.</span>
            <span tagx="pubdate">1993</span>
            <span tagx="volume">88</span>
            <span tagx="fpage">107</span>
            <span tagx="lpage">115</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1161/01.CIR.88.1.107</span>
                  <span tagx="pubid">8319323</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction:
                  5 year mortality follow-up of the Echocardiographic Heart of England Screening Study
                  (ECHOES)
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Hobbs</span>
                  <span tagx="fnm">FD</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Roalfe</span>
                  <span tagx="fnm">AK</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Davis</span>
                  <span tagx="fnm">RC</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Davies</span>
                  <span tagx="fnm">MK</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hare</span>
                  <span tagx="fnm">R</span>
               </li>
            </ul>
            <ul tagx="insg">
               <li tagx="ins">
                  <p>Midlands Research Practices Consortium (MidReC)</p>
               </li>
            </ul>
            <span tagx="source">Eur Heart J.</span>
            <span tagx="pubdate">2007</span>
            <span tagx="volume">28</span>
            <span tagx="fpage">1128</span>
            <span tagx="lpage">1134</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1093/eurheartj/ehm102</span>
                  <span tagx="pubid">17459902</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>More “malignant” than cancer? Five-year survival following a first admission for heart
                  failure
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Stewart</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">MacIntyre</span>
                  <span tagx="fnm">K</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hole</span>
                  <span tagx="fnm">DJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Capewell</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">McMurray</span>
                  <span tagx="fnm">JJ</span>
               </li>
            </ul>
            <span tagx="source">Eur J Heart Fail.</span>
            <span tagx="pubdate">2001</span>
            <span tagx="volume">3</span>
            <span tagx="fpage">315</span>
            <span tagx="lpage">322</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/S1388-9842(00)00141-0</span>
                  <span tagx="pubid">11378002</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Long-term trends in the incidence of and survival with heart failure</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Levy</span>
                  <span tagx="fnm">D</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kenchaiah</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Larson</span>
                  <span tagx="fnm">MG</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Benjamin</span>
                  <span tagx="fnm">EJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kupka</span>
                  <span tagx="fnm">MJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ho</span>
                  <span tagx="fnm">KK</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Murabito</span>
                  <span tagx="fnm">JM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Vasan</span>
                  <span tagx="fnm">RS</span>
               </li>
            </ul>
            <span tagx="source">N Engl J Med.</span>
            <span tagx="pubdate">2002</span>
            <span tagx="volume">347</span>
            <span tagx="fpage">1397</span>
            <span tagx="lpage">1402</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1056/NEJMoa020265</span>
                  <span tagx="pubid">12409541</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Prevalence and prognostic significance of heart failure stages: application of the
                  American College of Cardiology/American Heart Association heart failure staging criteria
                  in the community
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Ammar</span>
                  <span tagx="fnm">KA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Jacobsen</span>
                  <span tagx="fnm">SJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Mahoney</span>
                  <span tagx="fnm">DW</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kors</span>
                  <span tagx="fnm">JA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Redfield</span>
                  <span tagx="fnm">MM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Burnett</span>
                  <span tagx="fnm">JC</span>
                  <div tagx="suf">Jr</div>
               </li>
               <li tagx="au">
                  <span tagx="snm">Rodeheffer</span>
                  <span tagx="fnm">RJ</span>
               </li>
            </ul>
            <span tagx="source">Circulation.</span>
            <span tagx="pubdate">2007</span>
            <span tagx="volume">115</span>
            <span tagx="fpage">1563</span>
            <span tagx="lpage">1570</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1161/CIRCULATIONAHA.106.666818</span>
                  <span tagx="pubid">17353436</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart
                  Failure in Adults: a report of the American College of Cardiology Foundation/American
                  Heart Association Task Force on Practice Guidelines: developed in collaboration with
                  the International Society for Heart and Lung Transplantation
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Jessup</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Abraham</span>
                  <span tagx="fnm">WT</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Casey</span>
                  <span tagx="fnm">DE</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Feldman</span>
                  <span tagx="fnm">AM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Francis</span>
                  <span tagx="fnm">GS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ganiats</span>
                  <span tagx="fnm">TG</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Konstam</span>
                  <span tagx="fnm">MA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Mancini</span>
                  <span tagx="fnm">DM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Rahko</span>
                  <span tagx="fnm">PS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Silver</span>
                  <span tagx="fnm">MA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Stevenson</span>
                  <span tagx="fnm">LW</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Yancy</span>
                  <span tagx="fnm">CW</span>
               </li>
            </ul>
            <span tagx="source">Circulation.</span>
            <span tagx="pubdate">2009</span>
            <span tagx="volume">119</span>
            <span tagx="fpage">1977</span>
            <span tagx="lpage">2016</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1161/CIRCULATIONAHA.109.192064</span>
                  <span tagx="pubid">19324967</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
                  2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure
                  2008 of the European Society of Cardiology. Developed in collaboration with the Heart
                  Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive
                  Care Medicine (ESICM)
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Dickstein</span>
                  <span tagx="fnm">K</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Cohen-Solal</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Filippatos</span>
                  <span tagx="fnm">G</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">McMurray</span>
                  <span tagx="fnm">JJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ponikowski</span>
                  <span tagx="fnm">P</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Poole-Wilson</span>
                  <span tagx="fnm">PA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Strömberg</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">van Veldhuisen</span>
                  <span tagx="fnm">DJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Atar</span>
                  <span tagx="fnm">D</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hoes</span>
                  <span tagx="fnm">AW</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Keren</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Mebazaa</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Nieminen</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Priori</span>
                  <span tagx="fnm">SG</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Swedberg</span>
                  <span tagx="fnm">K</span>
               </li>
            </ul>
            <ul tagx="insg">
               <li tagx="ins">
                  <p>ESC Committee for Practice Guidelines (CPG)</p>
               </li>
            </ul>
            <span tagx="source">Eur Heart J.</span>
            <span tagx="pubdate">2008</span>
            <span tagx="volume">29</span>
            <span tagx="fpage">2388</span>
            <span tagx="lpage">2442</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1093/eurheartj/ehn309</span>
                  <span tagx="pubid">18799522</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>The effect of cardiac resynchronization on morbidity and mortality in heart failure</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Cleland</span>
                  <span tagx="fnm">JG</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Daubert</span>
                  <span tagx="fnm">JC</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Erdmann</span>
                  <span tagx="fnm">E</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Freemantle</span>
                  <span tagx="fnm">N</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Gras</span>
                  <span tagx="fnm">D</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kappenberger</span>
                  <span tagx="fnm">L</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Tavazzi</span>
                  <span tagx="fnm">L</span>
               </li>
            </ul>
            <ul tagx="insg">
               <li tagx="ins">
                  <p>Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators</p>
               </li>
            </ul>
            <span tagx="source">N Eng J Med.</span>
            <span tagx="pubdate">2005</span>
            <span tagx="volume">352</span>
            <span tagx="fpage">1539</span>
            <span tagx="lpage">1549</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1056/NEJMoa050496</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force
                  for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of
                  Cardiology. Developed in collaboration with the European Heart Rhythm Association
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Vardas</span>
                  <span tagx="fnm">PE</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Auricchio</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Blanc</span>
                  <span tagx="fnm">JJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Daubert</span>
                  <span tagx="fnm">JC</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Drexler</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ector</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Gasparini</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Linde</span>
                  <span tagx="fnm">C</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Morgado</span>
                  <span tagx="fnm">FB</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Oto</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Sutton</span>
                  <span tagx="fnm">R</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Trusz-Gluza</span>
                  <span tagx="fnm">M</span>
               </li>
            </ul>
            <ul tagx="insg">
               <li tagx="ins">
                  <p>European Society of Cardiology; European Heart Rhythm Association</p>
               </li>
            </ul>
            <span tagx="source">Europace</span>
            <span tagx="pubdate">2007</span>
            <span tagx="volume">9</span>
            <span tagx="fpage">959</span>
            <span tagx="lpage">998</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1093/europace/eum189</span>
                  <span tagx="pubid">17726043</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Comparative effects of permanent biventricular and right-univentricular pacing in
                  heart failure patients with chronic atrial fibrillation
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Leclercq</span>
                  <span tagx="fnm">C</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Walker</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Linde</span>
                  <span tagx="fnm">C</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Clementy</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Marshall</span>
                  <span tagx="fnm">AJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ritter</span>
                  <span tagx="fnm">P</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Djiane</span>
                  <span tagx="fnm">P</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Mabo</span>
                  <span tagx="fnm">P</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Levy</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Gadler</span>
                  <span tagx="fnm">F</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bailleul</span>
                  <span tagx="fnm">C</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Daubert</span>
                  <span tagx="fnm">JC</span>
               </li>
            </ul>
            <span tagx="source">Eur Heart J.</span>
            <span tagx="pubdate">2002</span>
            <span tagx="volume">23</span>
            <span tagx="fpage">1780</span>
            <span tagx="lpage">1787</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1053/euhj.2002.3232</span>
                  <span tagx="pubid">12419298</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Randomized, controlled trial of long-term moderate exercise training in chronic heart
                  failure: effects on functional capacity, quality of life, and clinical outcome
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Belardinelli</span>
                  <span tagx="fnm">R</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Georgiou</span>
                  <span tagx="fnm">D</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Cianci</span>
                  <span tagx="fnm">G</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Purcaro</span>
                  <span tagx="fnm">A</span>
               </li>
            </ul>
            <span tagx="source">Circulation.</span>
            <span tagx="pubdate">1999</span>
            <span tagx="volume">99</span>
            <span tagx="fpage">1173</span>
            <span tagx="lpage">1182</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1161/01.CIR.99.9.1173</span>
                  <span tagx="pubid">10069785</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Exercise and heart failure: a statement from the American Heart Association Committee
                  on exercise, rehabilitation, and prevention
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Piña</span>
                  <span tagx="fnm">IL</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Apstein</span>
                  <span tagx="fnm">CS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Balady</span>
                  <span tagx="fnm">GJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Belardinelli</span>
                  <span tagx="fnm">R</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Chaitman</span>
                  <span tagx="fnm">BR</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Duscha</span>
                  <span tagx="fnm">BD</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Fletcher</span>
                  <span tagx="fnm">BJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Fleg</span>
                  <span tagx="fnm">JL</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Myers</span>
                  <span tagx="fnm">JN</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Sullivan</span>
                  <span tagx="fnm">MJ</span>
               </li>
            </ul>
            <ul tagx="insg">
               <li tagx="ins">
                  <p>American Heart Association Committee on Exercise, Rehabilitation, and Prevention</p>
               </li>
            </ul>
            <span tagx="source">Circulation</span>
            <span tagx="pubdate">2003</span>
            <span tagx="volume">107</span>
            <span tagx="fpage">1210</span>
            <span tagx="lpage">1225</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1161/01.CIR.0000055013.92097.40</span>
                  <span tagx="pubid">12615804</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Exercise training in patients with severe congestive heart failure: enhancing peak
                  aerobic capacity while minimizing the increase in ventricular wall stress
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Demopoulos</span>
                  <span tagx="fnm">L</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bijou</span>
                  <span tagx="fnm">R</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Fergus</span>
                  <span tagx="fnm">I</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Jones</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Strom</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">LeJemtel</span>
                  <span tagx="fnm">TH</span>
               </li>
            </ul>
            <span tagx="source">J Am Coll Cardiol.</span>
            <span tagx="pubdate">1997</span>
            <span tagx="volume">29</span>
            <span tagx="fpage">597</span>
            <span tagx="lpage">603</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/S0735-1097(96)00526-8</span>
                  <span tagx="pubid">9060899</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Waon therapy: soothing warmth therapy</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Tei</span>
                  <span tagx="fnm">C</span>
               </li>
            </ul>
            <span tagx="source">J Cardiol.</span>
            <span tagx="pubdate">2007</span>
            <span tagx="volume">49</span>
            <span tagx="fpage">301</span>
            <span tagx="lpage">304</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">17633566</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Beneficial effects of Waon therapy on patients with chronic heart failure: results
                  of a prospective multicenter study
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Miyata</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kihara</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kubozono</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ikeda</span>
                  <span tagx="fnm">Y</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Shinsato</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Izumi</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Matsuzaki</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Yamaguchi</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kasanuki</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Daida</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Nagayama</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Nishigami</span>
                  <span tagx="fnm">K</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hirata</span>
                  <span tagx="fnm">K</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kihara</span>
                  <span tagx="fnm">K</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Tei</span>
                  <span tagx="fnm">C</span>
               </li>
            </ul>
            <span tagx="source">J Cardiol.</span>
            <span tagx="pubdate">2008</span>
            <span tagx="volume">52</span>
            <span tagx="fpage">79</span>
            <span tagx="lpage">85</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.jjcc.2008.07.009</span>
                  <span tagx="pubid">18922381</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Coronary artery bypass grafting in severe left ventricular dysfunction: excellent
                  survival with improved ejection fraction and functional state
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Elefteriades</span>
                  <span tagx="fnm">JA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Tolis</span>
                  <span tagx="fnm">G</span>
                  <div tagx="suf">Jr</div>
               </li>
               <li tagx="au">
                  <span tagx="snm">Levi</span>
                  <span tagx="fnm">E</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Mills</span>
                  <span tagx="fnm">LK</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Zaret</span>
                  <span tagx="fnm">BL</span>
               </li>
            </ul>
            <span tagx="source">J Am Coll Cardiol.</span>
            <span tagx="pubdate">1993</span>
            <span tagx="volume">22</span>
            <span tagx="fpage">1411</span>
            <span tagx="lpage">1417</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/0735-1097(93)90551-B</span>
                  <span tagx="pubid">8227799</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Results and predictors of early and late outcome of coronary artery bypass grafting
                  in patients with severely depressed left ventricular function
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Filsoufi</span>
                  <span tagx="fnm">F</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Rahmanian</span>
                  <span tagx="fnm">PB</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Castillo</span>
                  <span tagx="fnm">JG</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Chikwe</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kini</span>
                  <span tagx="fnm">AS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Adams</span>
                  <span tagx="fnm">DH</span>
               </li>
            </ul>
            <span tagx="source">Ann Thorac Surg.</span>
            <span tagx="pubdate">2007</span>
            <span tagx="volume">84</span>
            <span tagx="fpage">808</span>
            <span tagx="lpage">816</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.athoracsur.2007.04.117</span>
                  <span tagx="pubid">17720380</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Intermediate-term outcome of mitral reconstruction in cardiomyopathy</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Bolling</span>
                  <span tagx="fnm">SF</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Pagani</span>
                  <span tagx="fnm">FD</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Deeb</span>
                  <span tagx="fnm">GM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bach</span>
                  <span tagx="fnm">DS</span>
               </li>
            </ul>
            <span tagx="source">J Thorac Cardiovasc Surg.</span>
            <span tagx="pubdate">1998</span>
            <span tagx="volume">115</span>
            <span tagx="fpage">381</span>
            <span tagx="lpage">386</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/S0022-5223(98)70282-X</span>
                  <span tagx="pubid">9475533</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Mitral valve surgery for chronic ischemic mitral regurgitation</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Calafiore</span>
                  <span tagx="fnm">AM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Di Mauro</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Gallina</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Di Giammarco</span>
                  <span tagx="fnm">G</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Iacò</span>
                  <span tagx="fnm">AL</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Teodori</span>
                  <span tagx="fnm">G</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Tavarozzi</span>
                  <span tagx="fnm">I</span>
               </li>
            </ul>
            <span tagx="source">Ann Thorac Surg.</span>
            <span tagx="pubdate">2004</span>
            <span tagx="volume">77</span>
            <span tagx="fpage">1989</span>
            <span tagx="lpage">1997</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.athoracsur.2003.11.017</span>
                  <span tagx="pubid">15172252</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="note">Guidelines for the evaluation and management of heart failure. Report of the American
               College of Cardiology/American Heart Association Task Force on Practice Guidelines
               (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol. 1995;26:1376–98
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Ventricular assist systems: experience in Japan with Toyobo pump and Zeon pump</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Takano</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Nakatani</span>
                  <span tagx="fnm">T</span>
               </li>
            </ul>
            <span tagx="source">Ann Thorac Surg.</span>
            <span tagx="pubdate">1996</span>
            <span tagx="volume">61</span>
            <span tagx="fpage">317</span>
            <span tagx="lpage">322</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/0003-4975(95)01007-6</span>
                  <span tagx="pubid">8561597</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>ACC/AHA guidelines for the evaluation and management of chronic heart failure in the
                  adult: executive summary. A report of the American College of Cardiology/American
                  Heart Association Task Force on Practice Guidelines (Committee to revise the 1995
                  Guidelines for the Evaluation and Management of Heart Failure)
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Hunt</span>
                  <span tagx="fnm">SA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Baker</span>
                  <span tagx="fnm">DW</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Chin</span>
                  <span tagx="fnm">MH</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Cinquegrani</span>
                  <span tagx="fnm">MP</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Feldman</span>
                  <span tagx="fnm">AM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Francis</span>
                  <span tagx="fnm">GS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ganiats</span>
                  <span tagx="fnm">TG</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Goldstein</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Gregoratos</span>
                  <span tagx="fnm">G</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Jessup</span>
                  <span tagx="fnm">ML</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Noble</span>
                  <span tagx="fnm">RJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Packer</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Silver</span>
                  <span tagx="fnm">MA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Stevenson</span>
                  <span tagx="fnm">LW</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Gibbons</span>
                  <span tagx="fnm">RJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Antman</span>
                  <span tagx="fnm">EM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Alpert</span>
                  <span tagx="fnm">JS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Faxon</span>
                  <span tagx="fnm">DP</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Fuster</span>
                  <span tagx="fnm">V</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Jacobs</span>
                  <span tagx="fnm">AK</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hiratzka</span>
                  <span tagx="fnm">LF</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Russell</span>
                  <span tagx="fnm">RO</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Smith</span>
                  <span tagx="fnm">SC</span>
                  <div tagx="suf">Jr</div>
               </li>
            </ul>
            <ul tagx="insg">
               <li tagx="ins">
                  <p>American College of Cardiology/American Heart Association</p>
               </li>
            </ul>
            <span tagx="source">J Am Coll Cardiol.</span>
            <span tagx="pubdate">2001</span>
            <span tagx="volume">38</span>
            <span tagx="fpage">2101</span>
            <span tagx="lpage">2113</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/S0735-1097(01)01683-7</span>
                  <span tagx="pubid">11738322</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>What are the costs of heart failure?</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Braunschweig</span>
                  <span tagx="fnm">F</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Cowie</span>
                  <span tagx="fnm">MR</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Auricchio</span>
                  <span tagx="fnm">A</span>
               </li>
            </ul>
            <span tagx="source">Europace</span>
            <span tagx="pubdate">2011</span>
            <span tagx="volume">13</span>
            <span tagx="issue">Suppl 2</span>
            <span tagx="fpage">ii13</span>
            <span tagx="lpage">ii17</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1093/europace/eur081</span>
                  <span tagx="pubid">21518742</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="note">Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention
               Trial in Congestive Heart Failure (MERIT-HF). Lancet
               <i>.</i> 1999;353
               <b>:</b>2001
               <b>–</b>0
               <b>7</b>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Effects of positive end-expiratory pressure ventilation and extracorporeal ultrafiltration
                  method in patients with refractory heart failure
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Takano</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Endo</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Tanaka</span>
                  <span tagx="fnm">K</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Seino</span>
                  <span tagx="fnm">Y</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Nitta</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Matsuyama</span>
                  <span tagx="fnm">Y</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Koh</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hayakawa</span>
                  <span tagx="fnm">H</span>
               </li>
            </ul>
            <span tagx="source">Jpn Circ J.</span>
            <span tagx="pubdate">1986</span>
            <span tagx="volume">50</span>
            <span tagx="fpage">359</span>
            <span tagx="lpage">367</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1253/jcj.50.359</span>
                  <span tagx="pubid">3528548</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Noninvasive ventilation</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Mehta</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hill</span>
                  <span tagx="fnm">NS</span>
               </li>
            </ul>
            <span tagx="source">Am J Respir Crit Care Med.</span>
            <span tagx="pubdate">2001</span>
            <span tagx="volume">163</span>
            <span tagx="fpage">540</span>
            <span tagx="lpage">577</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1164/ajrccm.163.2.9906116</span>
                  <span tagx="pubid">11179136</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Effect of continuous positive airway pressure on intrathoracic and left ventricular
                  transmural pressures in patients with congestive heart failure
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Naughton</span>
                  <span tagx="fnm">MT</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Rahman</span>
                  <span tagx="fnm">MA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hara</span>
                  <span tagx="fnm">K</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Floras</span>
                  <span tagx="fnm">JS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bradley</span>
                  <span tagx="fnm">TD</span>
               </li>
            </ul>
            <span tagx="source">Circulation</span>
            <span tagx="pubdate">1995</span>
            <span tagx="volume">91</span>
            <span tagx="fpage">1725</span>
            <span tagx="lpage">1731</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1161/01.CIR.91.6.1725</span>
                  <span tagx="pubid">7882480</span>
               </div>
            </div>
         </div>
      </div>
   </div>
</html>